J&J booster shot slashes Omicron hospitalisations - South African study
Published: Dec 30, 2021 8:45 AM
A booster dose of Johnson & Johnson Inc's single-dose Covid-19 vaccine was 84 percent effective at preventing hospitalisation in South African healthcare workers who became infected as the Omicron variant spread, researchers said on Thursday.
The real-world study, which has not been peer-reviewed, was based on a second dose of the J&J vaccine administered to 69,092 workers between Nov 15 and Dec. 20...
View Comments0
Report this comment
500 characters remaining
Are you sure you want to delete this comment?
This action cannot be undone.